The Pharma Data

DECEMBER 15, 2020

FDA Approves First Over-the-Counter Fully At-Home Test for COVID-19. Last week, the FDA approved a different at-home test, but it requires samples to be mailed to a lab to get the results. Last week, the FDA approved a different at-home test, but it requires samples to be mailed to a lab to get the results.

FDA Approval 52

FDA Approval Radiology Protein Drugs 52

The Pharma Data

DECEMBER 15, 2020

” Last week, the FDA approved a different at-home test, but it requires samples to be mailed to a lab to get the results. The new Ellume COVID-19 Home Test approved Tuesday detects SARS-CoV-2 virus protein fragments on nasal swab samples from any person 2 years of age or older, according to the FDA.

FDA Approval 52

FDA Approval Radiology Doctors Doctor 52

XTalks

JUNE 12, 2023

Additionally, Abbott launched over 125 new products in 2022, in conjunction with a series of FDA approvals. This system is the first and only FDA-approved heart failure monitoring system that enables physicians to track changes in pulmonary artery pressure. The CardioMEMs HF system was another crucial launch for Abbott.

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

XTalks

NOVEMBER 7, 2022

Immunofluorescent staining of CTCs is a CTC isolation method that has been used since the first US Food and Drug Administration (FDA) approval in 2013 for the CellSearch ® CTC enumeration platform. Regulatory Approvals for CTC-Based Assays in Oncology. Table 1: Some examples of cfDNA-based assays that are approved by the US FDA.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

The Pharma Data

APRIL 7, 2023

Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Applications (sNDAs) for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) for patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, as detected by an FDA-approved test. In the U.S.,

FDA Approval 40

FDA Approval Drugs Medicine Genetics 40

Intouch Solutions

JUNE 30, 2022

But brands are increasingly going to have to address this unfamiliarity, and normalize therapeutics that aren’t just made out of cellulose and proteins. Would it feel strange to get a prescription for VR? The connection will be tested this summer and the companies plan a big marketing push this autumn.

Pharmacy 52

Pharmacy Radiology Cosmetics Manufacturing 52

XTalks

AUGUST 30, 2022

Nusinersen was the first FDA-approved treatment for spinal muscular atrophy (SMA), the first approved nucleic-acid therapeutic for a neurologic disease and the first approved drug to correct defective splicing. What About Small Proteins and Antibodies Reaching Extracellular CNS Targets?

Trials 83

Trials Drug Delivery Drugs Gene 83